Literature DB >> 17012895

Applications of influenza virosomes as a delivery system.

Maria Grazia Cusi1.   

Abstract

The induction of effective cellular and humoral immune responses against antigens is the major goal in vaccination strategies against infectious diseases and cancer. In this review, we will discuss influenza virosomes as a versatile delivery system for molecules of a different nature, such as proteins, peptides and nucleic acids. These molecules can be administered in different ways, such as nasal, muscular or dermal routes, also facilitating the uptake of the antigen by antigen-presenting cells (APC) and inducing a specific humoral and cell-mediated immune response, particularly a CTL response. Influenza virosomes, due to their applicability in different medical fields, are a promising tool in vaccinology and immunotherapy applications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17012895     DOI: 10.4161/hv.2.1.2494

Source DB:  PubMed          Journal:  Hum Vaccin        ISSN: 1554-8600


  11 in total

1.  Delivery strategies for novel vaccine formulations.

Authors:  Maria Trovato; Shelly J Krebs; Nancy L Haigwood; Piergiuseppe De Berardinis
Journal:  World J Virol       Date:  2012-02-12

Review 2.  Current prospects and future challenges for nasal vaccine delivery.

Authors:  Helmy Yusuf; Vicky Kett
Journal:  Hum Vaccin Immunother       Date:  2016-12-09       Impact factor: 3.452

Review 3.  Recent trends and advances in microbe-based drug delivery systems.

Authors:  Pravin Shende; Vasavi Basarkar
Journal:  Daru       Date:  2019-08-02       Impact factor: 3.117

Review 4.  Biomimetic nanoparticles: preparation, characterization and biomedical applications.

Authors:  Ana Maria Carmona-Ribeiro
Journal:  Int J Nanomedicine       Date:  2010-04-07

5.  Correlative imaging using super-resolution fluorescence microscopy and soft X-ray tomography at cryogenic temperatures provides a new way to assess virosome solutions for vaccine development.

Authors:  Chidinma A Okolo; Archana Jadhav; Patrick Phillips; Maud Dumoux; Amanda A McMurray; Vishwas D Joshi; Claire Pizzey; Maria Harkiolaki
Journal:  J Microsc       Date:  2021-09-03       Impact factor: 1.952

Review 6.  Recent advances of vaccine adjuvants for infectious diseases.

Authors:  Sujin Lee; Minh Trang Nguyen
Journal:  Immune Netw       Date:  2015-04-23       Impact factor: 6.303

7.  Increase in DNA vaccine efficacy by virosome delivery and co-expression of a cytolytic protein.

Authors:  Tessa Gargett; Branka Grubor-Bauk; Darren Miller; Tamsin Garrod; Stanley Yu; Steve Wesselingh; Andreas Suhrbier; Eric J Gowans
Journal:  Clin Transl Immunology       Date:  2014-06-27

Review 8.  Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments.

Authors:  Stefania Cuzzubbo; Sara Mangsbo; Divya Nagarajan; Kinana Habra; Alan Graham Pockley; Stephanie E B McArdle
Journal:  Front Immunol       Date:  2021-02-17       Impact factor: 7.561

Review 9.  Vaccine adjuvants as potential cancer immunotherapeutics.

Authors:  Burcu Temizoz; Etsushi Kuroda; Ken J Ishii
Journal:  Int Immunol       Date:  2016-03-22       Impact factor: 4.823

Review 10.  Virus-like particles-universal molecular toolboxes.

Authors:  Christine Ludwig; Ralf Wagner
Journal:  Curr Opin Biotechnol       Date:  2007-12       Impact factor: 9.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.